• Je něco špatně v tomto záznamu ?

Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update

AR. Ramos, S. Ghosh, T. Suhel, C. Chevalier, EO. Obeng, B. Fafilek, P. Krejci, B. Beck, C. Erneux

. 2020 ; 75 (-) : 100660. [pub] 20191007

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012931

Phosphoinositides (PIs) are phosphorylated derivatives of phosphatidylinositol. They act as signaling molecules linked to essential cellular mechanisms in eukaryotic cells, such as cytoskeleton organization, mitosis, polarity, migration or invasion. PIs are phosphorylated and dephosphorylated by a large number of PI kinases and PI phosphatases acting at the 5-, 4- and 3- position of the inositol ring. PI 5-phosphatases i.e. OCRL, INPP5B, SHIP1/2, Synaptojanin 1/2, INPP5E, INPP5J, SKIP (INPP5K) are enzymes that dephosphorylate the 5-phosphate position of PIs. Several human genetic diseases such as the Lowe syndrome, some congenital muscular dystrophy and opsismodysplasia are due to mutations in PI phosphatases, resulting in loss-of-function. The PI phosphatases are also up or down regulated in several human cancers such as glioblastoma or breast cancer. Their cellular localization, that is dynamic and varies in response to stimuli, is an important issue to understand function. This is the case for two members of the PI 5-phosphatase SKIP and SHIP2. Both enzymes are in ruffles, plasma membranes, the endoplasmic reticulum, a situation that is unique for SKIP, and the nucleus. Following localization, PI 5-phosphatases act on specific cellular pools of PIs, which in turn interact with target proteins. Nuclear PIs have emerged as regulators of genome functions in different area of cell signaling. They often localize to nuclear speckles, as do several PI metabolizing kinases and phosphatases. We asked whether SKIP and SHIP2 could have an impact on nuclear PI(4,5)P2. In two glioblastoma cell models, lowering SKIP expression had an impact on nuclear PI(4,5)P2. In a model of SHIP2 deletion in MCF-7 cells, no change in nuclear PI(4,5)P2 was observed. Finally, we present evidence of an anti-tumoral role of SKIP in vivo, in xenografts using as model U87shSKIP cells.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012931
003      
CZ-PrNML
005      
20210507101538.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jbior.2019.100660 $2 doi
035    __
$a (PubMed)31628071
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Ramos, Ana Raquel $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 Route de Lennik, 1070, Bruxelles, Belgium
245    10
$a Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update / $c AR. Ramos, S. Ghosh, T. Suhel, C. Chevalier, EO. Obeng, B. Fafilek, P. Krejci, B. Beck, C. Erneux
520    9_
$a Phosphoinositides (PIs) are phosphorylated derivatives of phosphatidylinositol. They act as signaling molecules linked to essential cellular mechanisms in eukaryotic cells, such as cytoskeleton organization, mitosis, polarity, migration or invasion. PIs are phosphorylated and dephosphorylated by a large number of PI kinases and PI phosphatases acting at the 5-, 4- and 3- position of the inositol ring. PI 5-phosphatases i.e. OCRL, INPP5B, SHIP1/2, Synaptojanin 1/2, INPP5E, INPP5J, SKIP (INPP5K) are enzymes that dephosphorylate the 5-phosphate position of PIs. Several human genetic diseases such as the Lowe syndrome, some congenital muscular dystrophy and opsismodysplasia are due to mutations in PI phosphatases, resulting in loss-of-function. The PI phosphatases are also up or down regulated in several human cancers such as glioblastoma or breast cancer. Their cellular localization, that is dynamic and varies in response to stimuli, is an important issue to understand function. This is the case for two members of the PI 5-phosphatase SKIP and SHIP2. Both enzymes are in ruffles, plasma membranes, the endoplasmic reticulum, a situation that is unique for SKIP, and the nucleus. Following localization, PI 5-phosphatases act on specific cellular pools of PIs, which in turn interact with target proteins. Nuclear PIs have emerged as regulators of genome functions in different area of cell signaling. They often localize to nuclear speckles, as do several PI metabolizing kinases and phosphatases. We asked whether SKIP and SHIP2 could have an impact on nuclear PI(4,5)P2. In two glioblastoma cell models, lowering SKIP expression had an impact on nuclear PI(4,5)P2. In a model of SHIP2 deletion in MCF-7 cells, no change in nuclear PI(4,5)P2 was observed. Finally, we present evidence of an anti-tumoral role of SKIP in vivo, in xenografts using as model U87shSKIP cells.
650    _2
$a zvířata $7 D000818
650    _2
$a nádory prsu $x enzymologie $x genetika $x patologie $7 D001943
650    _2
$a buněčné jádro $x enzymologie $x genetika $7 D002467
650    _2
$a endoplazmatické retikulum $x enzymologie $x genetika $x patologie $7 D004721
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glioblastom $x enzymologie $x genetika $x patologie $7 D005909
650    _2
$a lidé $7 D006801
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední NOD $7 D016688
650    _2
$a myši SCID $7 D016513
650    _2
$a nádorové proteiny $x genetika $x metabolismus $7 D009363
650    _2
$a fosfatidylinositol-3,4,5-trisfosfát-5-fosfatasy $x genetika $x metabolismus $7 D000072183
650    _2
$a fosfatasy $x genetika $x metabolismus $7 D010744
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ghosh, Somadri $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 Route de Lennik, 1070, Bruxelles, Belgium
700    1_
$a Suhel, Tara $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 Route de Lennik, 1070, Bruxelles, Belgium
700    1_
$a Chevalier, Clément $u Center for Microscopy and Molecular Imaging ULB, 12 Rue des Professeurs Jeener et Brachet, 6041, Charleroi, Belgium
700    1_
$a Obeng, Eric Owusu $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 Route de Lennik, 1070, Bruxelles, Belgium; Department of Biomedical Sciences, University of Bologna, Via Irnerio, 48, 40126, Bologna, Italy
700    1_
$a Fafilek, Bohumil $u Department of Biology, Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic
700    1_
$a Krejci, Pavel $u Department of Biology, Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic
700    1_
$a Beck, Benjamin $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 Route de Lennik, 1070, Bruxelles, Belgium
700    1_
$a Erneux, Christophe $u IRIBHM, Campus Erasme, ULB Bâtiment C, 808 Route de Lennik, 1070, Bruxelles, Belgium. Electronic address: cerneux@ulb.ac.be
773    0_
$w MED00197234 $t Advances in biological regulation $x 2212-4934 $g Roč. 75, č. - (2020), s. 100660
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31628071 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507101538 $b ABA008
999    __
$a ok $b bmc $g 1651163 $s 1133310
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 75 $c - $d 100660 $e 20191007 $i 2212-4934 $m Advances in biological regulation $n Adv Biol Regul $x MED00197234
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...